Tokuaki Kurata is the founder of Anaeropharma Science. Anaeropharma Science has raised $13M in total funding. Latest round: Growth. Based in Tokyo, Japan.
Tokuaki Kurata is associated with Anaeropharma Science, a Japanese biopharmaceutical company founded in 2004. The company focuses on developing therapies for hypoxic solid tumors and metastatic/recurrent cancer using recombinant bifidobacterium-based delivery technology. Anaeropharma Science emphasizes its i-DPS platform for targeting the hypoxic environment in solid cancers.
Full founder directory · Investor directory · Company funding database · Fundraising library